This inventor holds 3 USPTO granted patents. Top assignees: Brandeis University, The Brigham and Women's Hospital, Inc., University of Georgia Research Foundation Inc. Active years: 2015-2018.
Company Filing History:


Years Active: 2015-2018
Title: Innovations and Contributions of Deviprasad R Gollapalli
Introduction
Deviprasad R Gollapalli is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds for treating gastrointestinal infections and enhancing protein degradation. With a total of three patents to his name, Gollapalli's work has the potential to impact various therapeutic areas.
Latest Patents
Gollapalli's latest patents include innovative compounds and methods for treating mammalian gastrointestinal microbial infections. These compounds are designed to selectively inhibit a parasitic IMPDH, providing a targeted approach to treatment. Additionally, he has developed small-molecule-targeted protein degradation methods, which enhance the degradation of proteins implicated in various diseases. These inventions not only offer therapeutic solutions but also serve as valuable research tools for investigating protein function and degradation.
Career Highlights
Throughout his career, Gollapalli has worked with esteemed institutions such as Brandeis University and the University of Georgia Research Foundation, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Gollapalli has collaborated with notable colleagues, including Lizbeth K Hedstrom and Gregory D Cuny. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in pharmaceutical research.
Conclusion
Deviprasad R Gollapalli's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic approaches and research methodologies.